6-hydroxyindole and Uremia

6-hydroxyindole has been researched along with Uremia* in 1 studies

Other Studies

1 other study(ies) available for 6-hydroxyindole and Uremia

Article	Year
6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug metabolism and pharmacokinetics, 2020, Volume: 35, Issue:6 The hepatic uptake transporter organic anion transporting polypeptide (OATP) 1B1 is inhibited by some uremic toxins; however, direct inhibition can only partially explain the delayed systemic elimination of substrate drugs in renal failure patients. This study aimed to examine the long-lasting inhibition of OATP1B1 by uremic toxins and their metabolites. Preincubation of HEK293/OATP1B1 cells with 21 uremic toxins resulted in almost no change in the uptake of a typical substrate [ Topics: Biological Transport; Dose-Response Relationship, Drug; Estrone; HEK293 Cells; Hepatocytes; Humans; Indoles; Kinetics; Liver-Specific Organic Anion Transporter 1; Renal Insufficiency; Up-Regulation; Uremia	2020

Article

Year

6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients.

Drug metabolism and pharmacokinetics, 2020, Volume: 35, Issue:6

The hepatic uptake transporter organic anion transporting polypeptide (OATP) 1B1 is inhibited by some uremic toxins; however, direct inhibition can only partially explain the delayed systemic elimination of substrate drugs in renal failure patients. This study aimed to examine the long-lasting inhibition of OATP1B1 by uremic toxins and their metabolites. Preincubation of HEK293/OATP1B1 cells with 21 uremic toxins resulted in almost no change in the uptake of a typical substrate [

Topics: Biological Transport; Dose-Response Relationship, Drug; Estrone; HEK293 Cells; Hepatocytes; Humans; Indoles; Kinetics; Liver-Specific Organic Anion Transporter 1; Renal Insufficiency; Up-Regulation; Uremia

2020